Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,866
Sort by:
2018 Spain Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Spain ...
June 2018
565 pages
2018 UK Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the UK cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...
June 2018
565 pages
2018 Europe Cancer Diagnostics Market Segmentation Analysis: France, Germany, Italy, Spain, UK--Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 19,700.00
... identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the ... universe of laboratories performing cancer diagnostic testing by country. Cancer statistics, etiology and recent developments in Europe. Business Opportunities and Strategic ...
June 2018
820 pages
Kidney Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (Targeted Therapy, Immunotherapy), By Pharmacologic Class, By Country, And Segment Forecasts, 2016 - 2022
US$ 5,950.00
... kidney cancer drugs market size is expected to be valued at USD 6.3 billion by 2022, as per a new report by Grand View Research, Inc., registering a CAGR of 5.4% during the forecast period. Market ... hand, surge in kidney cancer screening is a key driver in markets such as EU Emerging markets in Asia Pacific and ...
June 2018
99 pages
Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) & Forecast
US$ 1,290.00
... cancer test market in the developing countries. Renub Research report titled “Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) & Forecast” provides a complete analysis of Asia Cervical Cancer ...
June 2018
Europe Cervical Cancer Diagnostic Market & Forecast, By Test Type (Pap smear and HPV DNA), Countries (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway and Netherlands)
US$ 1,290.00
... Cancer Diagnostic Market & Forecast, By Test Type (Pap smear and HPV DNA), Countries (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway and Netherlands)” provides a complete analysis of Europe Cervical Cancer Screening Market. The covers European Countries Cervical Cancer Test Market ...
June 2018
2018 Europe Cancer Diagnostics Market: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 19,700.00
... suggests alternative business expansion strategies for suppliers.strong> RationaleThe cancer diagnostics market is on the verge of explosion, as the researchers ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
June 2018
820 pages
Liver Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (Targeted Therapy, Immunotherapy), By Country (U.S., Japan, U.K., Germany, Spain, Italy, France), And Segment Forecasts, 2016 - 2022
US$ 5,950.00
The global liver cancer drugs market size is expected to be valued at USD 1.47 billion by 2022, as per a new report by Grand ... of 19.4% during the forecast period. The growth of liver cancer market is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rising public ...
June 2018
92 pages
Colorectal Cancer (CRC) Drugs/ Therapeutic Market Size, Share & Trends Analysis Report by Drug Class (Chemotherapy, Immunotherapy), By Country (U.S., U.K., Germany, Spain, Italy, France, Japan), And Segment Forecasts, 2016 - 2022
US$ 5,950.00
The global colorectal cancer (CRC) drugs market size is expected to reach ... some of the unmet needs of the colorectal cancer (CRC) market. If approved, Array Biopharma’s ... drugs Roche led the colorectal cancer industrial setting in 2016 due to growing usage of Avastin. Avastin was the highest revenue-generating CRC ...
June 2018
99 pages
Global Cancer Angiogenesis Inhibitor Industry Market Research 2018
US$ 2,600.00
... are the Cancer Angiogenesis Inhibitor market challenges to market growth? 10. What are the Cancer Angiogenesis Inhibitor market opportunities and threats faced by the vendors in the global Cancer Angiogenesis Inhibitor market ...
June 2018
156 pages
Global Cancer Immunotoxin Industry Market Research 2018
US$ 2,600.00
... of the Cancer Immunotoxin market? 9. What are the Cancer Immunotoxin market challenges to market growth? 10. What are the Cancer Immunotoxin market opportunities and threats faced by the vendors in the global Cancer Immunotoxin market? Objective of Studies ...
June 2018
155 pages
Global Cancer Testing Product Industry Market Research 2018
US$ 2,600.00
... are the Cancer Testing Product market challenges to market growth? 10. What are the Cancer Testing Product market opportunities and threats faced by the vendors in the global Cancer Testing Product market ...
May 2018
147 pages
Vulvar Cancer - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Vulvar Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Vulvar Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2018
125 pages
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H1 2018
US$ 3,500.00
... Wilms Tumor Protein (WT33 or WT1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2018
65 pages
Ovarian Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (PARP, PD-L1 Inhibitors , Angiogenesis), By Major Markets (U.S., U.K., Germany, Spain, Italy, France, Japan), And Segment Forecasts, 2016 - 2022
US$ 5,950.00
The global ovarian cancer drugs market size is expected to be valued at USD 4.5 billion by 2022, as per a new report by Grand ... to be the upcoming milestones for ovarian cancer treatment PARP inhibitors are anticipated to be the fastest growing drug class in the ovarian cancer market through the forecast period ...
May 2018
94 pages
Breast Cancer: KOL Insight [2018]
US$ 8,495.00
... triple-negative breast cancer and the potential usage of PD-1/PD-L1 checkpoint inhibitors is also explored. Twelve US and EU KOLs offer their candid insights on these ... how checkpoint inhibitors may be used in triple-negative breast cancer (TNBC). What are KOLs’ thoughts on these agents and how do they ...
April 2018
Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023
US$ 16,000.00
... .” Based on cancer type, the oncology nutrition market is segmented into head & neck cancers, stomach & gastrointestinal cancers, pancreatic cancer, liver cancer, esophageal cancer, lung cancer, breast cancer, blood cancer, and other cancers. The ...
April 2018
97 pages
Global Breast Cancer Market: Industry Analysis & Outlook (2018-2022)
US$ 800.00
... history and personal history are linked to the growth of breast cancer. The global breast cancer market is likely to grow strongly in the coming years driven ... countries, long term side effects of drugs. The report “Global Breast Cancer Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics ...
April 2018
82 pages
Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2022
US$ 1,375.00
... markets for novel products, diagnostics and therapeutics development. The report covers the regulatory environment, current and new technologies, ovarian cancer incidence, market projections and market ... covers global and regional markets for ovarian cancer diagnostics and therapies, providing reasons for ...
April 2018
168 pages
Prostate Cancer: Update Bulletin #2 [April 2018]
US$ 1,095.00
... opinion leader (KOL) insights on the latest events happening in the prostate cancer space. Topics covered include expert opinions on the FDA approval ... inhibitor Erleada (apalutamide) in patients with non-metastatic castration-resistant prostate cancer (CRPC), data published from the PROSPER study for Pfizer ...
March 2018
Ovarian Cancer: KOL Insight
US$ 8,495.00
... play a role? Twelve of the world’s leading KOLs from the US and Europe offer candid insights on four marketed therapies and nine Phase ... ? Could ImmunoGen’s antibody-drug conjugate IMGN853 have a potential role in ovarian cancer? KOLs debate the potential advantages and pitfalls to this novel approach ...
March 2018
Cancer Immunotherapy Market
US$ 3,619.00
... FROM THE CANCER IMMUNOTHERAPY MARKET REPORT The report provides a comprehensive analysis of the cancer immunotherapy market, incorporating the market size, market share analysis, market classification, market comparison analysis, market status ...
March 2018
Colorectal Cancer Diagnostic and Treatment Market - Forecasts from 2018 to 2023
US$ 3,800.00
... hold a significant market share in the global colorectal cancer diagnostic and treatment market. This research study examines the current market ... clients in gaining faster and efficient understanding of the global colorectal cancer diagnostic and treatment market. Major industry players profiled as part of the ...
March 2018
89 pages
